HYPHEN BioMed was created in 1999, by Mrs. Anne Marie Vissac and Dr Jean Amiral, researchers in applied biology with considerable industrial experience, in order to bring to medical and pharmaceutical research and hospital laboratories innovative tools for research and specialized biological diagnostics in thrombosis, hemostasis and auto immune diseases. When HYPHEN BioMed joined Sysmex Corporation in 2010, world leader in hematology and aiming to become one of the leading global diagnostics companies, HYPHEN BioMed, a leader in technological innovation in hemostasis, is giving itself the means for an ambitious future. HYPHEN BioMed is positioning itself as the scientific and technical center of expertise worldwide for the Sysmex Corporation hemostasis activities, and more particularly for research, innovation and academic relations and specialized industrial partners. HYPHEN BioMed's activity is focused on its technical and scientific know-how. Collaborations have been established with specialized distributors, well introduced in their territories. They have the technical and scientific expertise required to understand the products, promote their applications and offer all the expected support to customers.